Monomethyl fumarate Recruiting Phase 2 Trials for Gout Chronic Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03303989REduCing Immunogenicity to PegloticasE (RECIPE) Study